European guidelines mention permethrin, benzyl benzoate and crotamiton as topical antiscabiosa. There have been repeated reports of treatment failure with permethrin in recent years, although the causes are controversial. In order to directly compare permethrin 5% with benzyl benzoate 25%, an Austrian research team conducted a double-blind randomized study.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Atopic dermatitis
Implement the “minimal disease activity” concept
- Sensation of pain
Special features for people with multiple disabilities
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Atopic dermatitis
Clinic, therapy and prevention in early childhood
- Electrolyte disturbance
Hyponatremia in the outpatient setting
- Pain and autism
Hurdles to pain treatment for autistic patients
- Chronic musculoskeletal pain
How can the use of analgesics be optimized in multimodal therapy?
- Findings from the TRACK-FA study